DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,822,400 | +61.9% | 315,000 | +103.2% | 1.47% | +11.5% |
| Q2 2023 | $1,743,750 | -2.3% | 155,000 | 0.0% | 1.32% | +33.2% |
| Q1 2023 | $1,785,600 | -9.9% | 155,000 | -7.0% | 0.99% | +81.5% |
| Q4 2021 | $1,981,000 | -26.8% | 166,636 | 0.0% | 0.55% | -23.1% |
| Q3 2021 | $2,706,000 | -22.8% | 166,636 | 0.0% | 0.71% | -12.7% |
| Q2 2021 | $3,506,000 | +35.5% | 166,636 | 0.0% | 0.81% | +13.2% |
| Q1 2021 | $2,588,000 | – | 166,636 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |